Candida sp. Infections in Patients with Diabetes Mellitus

Candidiasis has increased substantially worldwide over recent decades and is a significant cause of morbidity and mortality, especially among critically ill patients. Diabetes mellitus (DM) is a metabolic disorder that predisposes individuals to fungal infections, including those related to Candida...

Full description

Bibliographic Details
Main Authors: Célia F. Rodrigues, Maria Elisa Rodrigues, Mariana Henriques
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:http://www.mdpi.com/2077-0383/8/1/76
id doaj-5eb35228778845c299abc7c0b5302206
record_format Article
spelling doaj-5eb35228778845c299abc7c0b53022062020-11-25T00:03:49ZengMDPI AGJournal of Clinical Medicine2077-03832019-01-01817610.3390/jcm8010076jcm8010076Candida sp. Infections in Patients with Diabetes MellitusCélia F. Rodrigues0Maria Elisa Rodrigues1Mariana Henriques2CEB, Centre of Biological Engineering, LIBRO-Laboratório de Investigação em Biofilmes Rosário Oliveira, University of Minho, 4710-057 Braga, PortugalCEB, Centre of Biological Engineering, LIBRO-Laboratório de Investigação em Biofilmes Rosário Oliveira, University of Minho, 4710-057 Braga, PortugalCEB, Centre of Biological Engineering, LIBRO-Laboratório de Investigação em Biofilmes Rosário Oliveira, University of Minho, 4710-057 Braga, PortugalCandidiasis has increased substantially worldwide over recent decades and is a significant cause of morbidity and mortality, especially among critically ill patients. Diabetes mellitus (DM) is a metabolic disorder that predisposes individuals to fungal infections, including those related to Candida sp., due to a immunosuppressive effect on the patient. This review aims to discuss the latest studies regarding the occurrence of candidiasis on DM patients and the pathophysiology and etiology associated with these co-morbidities. A comprehensive review of the literature was undertaken. PubMed, Scopus, Elsevier’s ScienceDirect, and Springer’s SpringerLink databases were searched using well-defined search terms. Predefined inclusion and exclusion criteria were applied to classify relevant manuscripts. Results of the review show that DM patients have an increased susceptibility to Candida sp. infections which aggravates in the cases of uncontrolled hyperglycemia. The conclusion is that, for these patients, the hospitalization periods have increased and are commonly associated with the prolonged use of indwelling medical devices, which also increase the costs associated with disease management.http://www.mdpi.com/2077-0383/8/1/76Candidabiofilmsdiabetesmedical devicescandidiasismetabolic disorderhyperglycemiainfection
collection DOAJ
language English
format Article
sources DOAJ
author Célia F. Rodrigues
Maria Elisa Rodrigues
Mariana Henriques
spellingShingle Célia F. Rodrigues
Maria Elisa Rodrigues
Mariana Henriques
Candida sp. Infections in Patients with Diabetes Mellitus
Journal of Clinical Medicine
Candida
biofilms
diabetes
medical devices
candidiasis
metabolic disorder
hyperglycemia
infection
author_facet Célia F. Rodrigues
Maria Elisa Rodrigues
Mariana Henriques
author_sort Célia F. Rodrigues
title Candida sp. Infections in Patients with Diabetes Mellitus
title_short Candida sp. Infections in Patients with Diabetes Mellitus
title_full Candida sp. Infections in Patients with Diabetes Mellitus
title_fullStr Candida sp. Infections in Patients with Diabetes Mellitus
title_full_unstemmed Candida sp. Infections in Patients with Diabetes Mellitus
title_sort candida sp. infections in patients with diabetes mellitus
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2019-01-01
description Candidiasis has increased substantially worldwide over recent decades and is a significant cause of morbidity and mortality, especially among critically ill patients. Diabetes mellitus (DM) is a metabolic disorder that predisposes individuals to fungal infections, including those related to Candida sp., due to a immunosuppressive effect on the patient. This review aims to discuss the latest studies regarding the occurrence of candidiasis on DM patients and the pathophysiology and etiology associated with these co-morbidities. A comprehensive review of the literature was undertaken. PubMed, Scopus, Elsevier’s ScienceDirect, and Springer’s SpringerLink databases were searched using well-defined search terms. Predefined inclusion and exclusion criteria were applied to classify relevant manuscripts. Results of the review show that DM patients have an increased susceptibility to Candida sp. infections which aggravates in the cases of uncontrolled hyperglycemia. The conclusion is that, for these patients, the hospitalization periods have increased and are commonly associated with the prolonged use of indwelling medical devices, which also increase the costs associated with disease management.
topic Candida
biofilms
diabetes
medical devices
candidiasis
metabolic disorder
hyperglycemia
infection
url http://www.mdpi.com/2077-0383/8/1/76
work_keys_str_mv AT celiafrodrigues candidaspinfectionsinpatientswithdiabetesmellitus
AT mariaelisarodrigues candidaspinfectionsinpatientswithdiabetesmellitus
AT marianahenriques candidaspinfectionsinpatientswithdiabetesmellitus
_version_ 1725431812806672384